AAMS Dermatology & Cosmetology · Vol. 2 · Issue 2 · 2025-06-12
Immunotherapy-Related Cutaneous Adverse Events: A Clinical Practice Guideline
Brown SJ, Mitchell PA, Lewis RC
Department of Dermatology, Memorial Sloan Kettering Cancer Center, New York, NY, United States¹; Division of Dermatology, Yale School of Medicine, New Haven, CT, United States²
Abstract
Evidence-based clinical practice guideline for management of immune checkpoint inhibitor-related cutaneous adverse events, developed through systematic review and Delphi consensus of international experts.
Keywords: Immunotherapy, Cutaneous Adverse Events, Clinical Guideline, Checkpoint Inhibitors, Dermatologic Oncology
Full Text